Assessment of efficiency and safety of application of the reproduced drug of Mertenil® according to MSCT-coronary angiography
Abstract
In article possibility of an assessment of efficiency of therapy by the reproduced drug Mertenil of production of JSC Gideon Richter (Hungary) appointed for the purpose of primary prevention of the cardiovascular diseases. Increase of level of lipoproteid of the low density is one of the most powerful risk factors of death. Today therapy of a statin is carried out both for secondary and for primary prevention of cardiovascular diseases. For an assessment of dynamics of atherosclerotic processat patients with the diagnosis: CHD hypercholesterolemia without visual verification of defeat of the proximal coronary course possibility of use of a multispiral computer tomography of coronary arteries with calculation of a coronary calcic index is considered.
About the Authors
A. A. Malov
Kazan State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
L. I. Feiskhanova
Kazan State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
References
1. Perk J, Backer G.D, Gohlke H et al. EHJ 2012; 33: 1635-701.
2. Бозина Е.Э., Кляшева Ю.М., Кляшев С.М. и др. Fundamental Research 2013; 5: 46-9.
3. Гиляревский С.Р., Орлов В.А., Кузьмина И.М. и др. Кардиология и сердечно - сосудистая хирургия. 2012; 4: 3-13.
4. Schuster H. Cardiovasc. Ther 2007; 5 (2): 177-93.
5. Nissen S.E, Nicholls S.J, Sipahy I et al. JAMA 2006; 295 (13): 1556-65.
6. Crouse J.R, Raichlen J.S, Riley W.A. JAMA 2007; 297: 1344-53.
7. Терновой С.К., Синицын В.Е., Гагарина Н.В. Неинвазивная диагностика атеросклероза и кальциноза коронарных артерий. М.: Атмосфера, 2003.
8. Arad Y, Goodman K.J, Roth M et al. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol 2005; 46 (1):158-65.
9. Синицын В.Е., Устюжанин Д.Ю. Мультиспиральная компьютерная томография: исследование коронарных артерий. Болезни сердца и сосудов. 2006; 1 (1).
10. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации, IV пересмотр. М., 2009.
11. Кобалава Ж.Д., Виллевальде С.В., Шаварова Е.К. Кардиоваскулярная терапия и профилактика. 2007; 6 (2): 105-12.
12. Underhill H.R, Yuan Ch, Zhao X-Q et al. Am Heart J 2008; 1: e1-e8.
13. Тарловская Е.И. Рус. мед. журн. 2008; 5: 333-7.
14. Brass L.M, Alberts M.J, Sparks L. Am J Cardiol 2006; 97 (Suppl. 8A): 86С-89C.
Review
For citations:
Malov A.A., Feiskhanova L.I. Assessment of efficiency and safety of application of the reproduced drug of Mertenil® according to MSCT-coronary angiography. Systemic Hypertension. 2016;13(2):24-27. (In Russ.)
Views:
103
Email this article 